NEUMORA THERAPEUTICS, INC. (NMRA) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $60.00M; Long-term Debt, Excluding Current MaturitiesUSD $52.91M; Long-term DebtUSD $52.91M; Long-Term Debt, Maturity, Year OneUSD $0.00.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $60.00M; Long-term Debt, Excluding Current MaturitiesUSD $52.96M; Long-term DebtUSD $52.96M; Long-Term Debt, Maturity, Year OneUSD $0.00.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $54.53M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $60.00M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $54.53M; Long-Term Debt, Maturity, Year OneUSD $0.00.
NEUMORA THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Debt Instrument, Fee Amount USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $60.00M | $52.91M | $52.91M | $0.00 | $0.00 | $0.00 | $58.17M | $4.20M | $58.17M | (m) |
| 2026-03-31 | $60.00M | $52.96M | $52.96M | $0.00 | $0.00 | $30.76M | $27.41M | $4.20M | $58.17M | (m) |
| 2025-12-31 | (m) | $54.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $60.00M | (m) | $54.53M | $0.00 | $0.00 | $31.93M | $28.29M | $4.20M | $60.22M | (m) |
| 2025-09-30 | $20.00M | $19.56M | $19.56M | $0.00 | $0.00 | $11.39M | $10.00M | $1.40M | $21.39M | $1.00M |
| 2025-06-30 | $20.00M | $19.45M | $19.45M | $0.00 | $0.00 | $11.39M | $10.00M | $1.40M | $21.39M | $1.10M |
| 2024-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |